CI The Cigna Group Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ 10-K/10-Q Lip 30, 2026CI Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
CI Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 5 czerwca 2007 | 3-for-1 | Naprzód |
| 18 maja 1998 | 3-for-1 | Naprzód |
O The Cigna Group Common Stock Przegląd firmy z Wikipedii
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products would be renamed Healthspring, which was a dormant brand name acquired as part of HCSC's deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | CI | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 12.7średnia z 5 lat ≈16.5 | ≈16.5 | 23.3 | Niedowartościowany | |
| P/S | 0.3średnia z 5 lat ≈0.4 | ≈0.4 | 1.3 | Niedowartościowany | |
| P/B | 1.9średnia z 5 lat ≈1.9 | ≈1.9 | 2.9 | Niedowartościowany | |
| EV / EBITDA | 6.0średnia z 5 lat ≈6.5 | ≈6.5 | 11.4 | Niedowartościowany | |
| Price / Cash Flow (Cena / Przepływy pieniężne) | 8.4średnia z 5 lat ≈8.8 | ≈8.8 | 9.8 | Niedowartościowany | |
| EV / Revenue (EV / Przychody) | 0.3średnia z 5 lat ≈0.4 | ≈0.4 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | CI | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 3.5%średnia z 5 lat ≈4.2% | ≈4.2% | 8.3% | Słaby | |
| Marża EBITDA (TTM) | 4.5%średnia z 5 lat ≈5.5% | ≈5.5% | 8.8% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 3.1%średnia z 5 lat ≈3.3% | ≈3.3% | 3.8% | Słaby | |
| Marża Zysku Netto (TTM) | 2.2%średnia z 5 lat ≈2.7% | ≈2.7% | 5.1% | Słaby | |
| ROA (TTM) | 4.0%średnia z 5 lat ≈3.6% | ≈3.6% | 4.0% | Zgodnie z | |
| ROE (TTM) | 15.0%średnia z 5 lat ≈12.1% | ≈12.1% | 12.5% | Zgodnie z | |
| ROIC | 17.8%średnia z 5 lat ≈15.9% | ≈15.9% | 9.2% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | CI | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.0średnia z 5 lat ≈0.0 | ≈0.0 | 0.4 | Niski dług | |
| Wskaźnik bieżący (MRQ) | 0.8średnia z 5 lat ≈0.8 | ≈0.8 | 1.4 | Niska płynność | |
| Wskaźnik Szybkości (MRQ) | 0.7średnia z 5 lat ≈0.6 | ≈0.6 | 0.8 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | CI | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 11.2%średnia z 5 lat ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 15.0%średnia z 5 lat ≈11.4% | ≈11.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 11.4% | · | · | · | |
| EPS YoY | 83.0%średnia z 5 lat ≈7.7% | ≈7.7% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 73.5%średnia z 5 lat ≈1.0% | ≈1.0% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 1.2%średnia z 5 lat ≈-5.3% | ≈-5.3% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -0.69% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -4.2%średnia z 5 lat ≈-11.2% | ≈-11.2% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -6.8% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | CI | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.8średnia z 5 lat ≈1.4 | ≈1.4 | 1.2 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 30.6średnia z 5 lat ≈29.9 | ≈29.9 | 15.6 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 10.4średnia z 5 lat ≈11.5 | ≈11.5 | 10.5 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$4.2M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 8, 2026 | $1,56 | USD | ≈2.2% |
| Cze 4, 2026 | $1,56 | USD | ≈2.2% |
| Mar 5, 2026 | $1,56 | USD | ≈2.2% |
| Gru 4, 2025 | $1,51 | USD | ≈2.3% |
| Wrz 4, 2025 | $1,51 | USD | ≈2.0% |
| Cze 3, 2025 | $1,51 | USD | ≈1.9% |
| Mar 5, 2025 | $1,51 | USD | ≈1.8% |
| Gru 4, 2024 | $1,40 | USD | ≈1.7% |
| Wrz 4, 2024 | $1,40 | USD | ≈1.5% |
| Cze 4, 2024 | $1,40 | USD | ≈1.6% |
| Mar 5, 2024 | $1,40 | USD | ≈1.5% |
| Gru 5, 2023 | $1,23 | USD | ≈1.9% |
| Wrz 5, 2023 | $1,23 | USD | ≈1.7% |
| Cze 6, 2023 | $1,23 | USD | ≈1.8% |
| Mar 7, 2023 | $1,23 | USD | ≈1.6% |
| Gru 5, 2022 | $1,12 | USD | ≈1.4% |
| Wrz 6, 2022 | $1,12 | USD | ≈1.5% |
| Cze 7, 2022 | $1,12 | USD | ≈1.6% |
| Mar 8, 2022 | $1,12 | USD | ≈1.8% |
| Gru 6, 2021 | $1,00 | USD | ≈1.9% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 29, 2026 | $7.78 | $7.83 | -0.59% |
| 31 marca 2026 | $7.79 | $7.84 | -0.65% | |
| 31 grudnia 2025 | $8.08 | $8.11 | -0.41% | |
| 30 września 2025 | $7.83 | $7.88 | -0.60% | |
| 30 czerwca 2025 | $7.20 | $7.37 | -2.3% | |
| 31 marca 2025 | $6.74 | $6.54 | 3.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $158.33 | $149.87 | $158.03 | $150.24 | $145.88 | $141.84 | $121.70 | $107.71 | · | · | |
| Revenue / Share | $1023.60 | $872.55 | $657.72 | $576.61 | $510.54 | $435.41 | $404.32 | $194.43 | · | · | |
| Cash Flow / Share | $35.75 | $36.59 | $39.79 | $27.65 | $21.09 | $28.10 | $24.97 | $15.07 | · | · | |
| Cash / Share | $29.13 | $27.58 | $26.74 | $19.83 | $15.73 | $28.70 | $12.40 | $10.12 | · | · | |
| Dividend / Share | $6.04 | $5.60 | $4.92 | $4.48 | $4.00 | $0.04 | $0.04 | $0.04 | $0.04 | · | |
| EPS (TTM) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | · | 267,530,000 | 268,154,000 | 272,953,000 | · | 281,396,000 | 284,052,000 | 286,465,000 | · | 297,131,000 | 296,879,000 | 298,999,000 | · | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $271.51 | $259.43 | · | $260.71 | $250.52 | $239.98 | · | $226.35 | $213.07 | $199.87 | · | $165.07 | $163.66 | $155.58 | · | $147.24 | |
| Cash Flow / Share | · | $4.28 | · | · | · | $7.03 | · | · | · | $16.90 | · | · | · | $16.82 | · | · | |
| Dividend / Share | $1.56 | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.40 | $1.40 | $1.40 | $1.40 | $1.23 | $1.23 | $1.23 | $1.23 | $1.12 | $1.12 | |
| EPS (TTM) | $24.17 | $23.59 | · | $22.55 | $18.20 | $17.94 | · | $10.60 | $12.71 | $12.18 | · | $17.72 | $21.95 | $21.92 | · | $20.99 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $282.38B | $277.89B | · | $268.08B | $262.02B | $255.37B | · | $232.59B | $217.94B | $206.00B | · | $189.90B | $186.14B | $183.03B | · | $180.44B | |
| Net Income TTM | $6.23B | $6.10B | · | $6.02B | $4.87B | $4.97B | · | $3.14B | $3.77B | $3.65B | · | $5.49B | $6.82B | $6.88B | · | $6.70B | |
| P/E | 11.4 | 11.3 | · | 12.8 | 18.2 | 18.3 | · | 32.7 | 26.0 | 29.8 | · | 16.1 | 12.8 | 11.7 | · | 13.2 | |
| Earnings Yield | 8.8% | 8.8% | · | 7.8% | 5.5% | 5.5% | · | 3.1% | 3.8% | 3.4% | · | 6.2% | 7.8% | 8.6% | · | 7.6% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · | |
| Annual Payout | $1.62B | $1.62B | · | $1.60B | $1.59B | $1.58B | · | $1.54B | $1.51B | $1.48B | · | $1.43B | $1.41B | $1.40B | · | $1.37B |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Marża Operacyjna % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Zysk netto | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| Rozwodniony EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Wskaźnik bieżący | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Wskaźnik Szybkości | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Zbyt mało danych fundamentalnych, aby utworzyć to sprawozdanie.
Właściciele instytucjonalni (13F) 1 838 emitentów · $73.2B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 160 (-30 vs poprzedni kw.) | 93 (-23 vs poprzedni kw.) | 686 (+29 vs poprzedni kw.) | 598 (+15 vs poprzedni kw.) | +5.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7 203 753 597 | 26 173 577 | 9,84% | Akcje |
| BlackRock, Inc. | $6 461 456 854 | 23 438 250 | 8,82% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 762 729 281 | 17 276 296 | 6,50% | Akcje |
| STATE STREET CORP | $3 496 245 161 | 12 682 259 | 4,77% | Akcje |
| Dodge & Cox | $3 356 093 871 | 12 173 875 | 4,58% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $2 895 610 431 | 10 443 691 | 3,95% | Akcje |
| Sanders Capital, LLC | $2 796 668 015 | 10 144 617 | 3,82% | Akcje |
| FMR LLC | $2 210 454 198 | 8 018 189 | 3,02% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 720 317 832 | 6 268 347 | 2,35% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 717 104 307 | 6 228 614 | 2,34% | Akcje |
| GQG Partners LLC | $1 628 918 123 | 5 908 707 | 2,22% | Akcje |
| JPMORGAN CHASE & CO | $1 447 877 312 | 5 194 363 | 1,98% | Akcje |
| MORGAN STANLEY | $1 017 483 597 | 3 690 812 | 1,39% | Akcje |
| NORGES BANK | $982 164 860 | 3 562 699 | 1,34% | Akcje |
| BANK OF AMERICA CORP /DE/ | $827 692 197 | 3 002 366 | 1,13% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785 495 575 | 2 849 302 | 1,07% | Akcje |
| NORTHERN TRUST CORP | $752 795 794 | 2 730 687 | 1,03% | Akcje |
| AMERIPRISE FINANCIAL INC | $719 183 166 | 2 608 447 | 0,98% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710 448 797 | 2 577 075 | 0,97% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $692 582 460 | 2 512 025 | 0,95% | Akcje |
| Invesco Ltd. | $662 627 873 | 2 403 612 | 0,90% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $656 057 221 | 2 459 446 | 0,90% | Akcje |
| Davis Selected Advisers | $621 243 564 | 2 253 424 | 0,85% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600 668 400 | 2 178 861 | 0,82% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558 018 223 | 2 024 152 | 0,76% | Akcje |
| Boston Partners | $555 607 176 | 2 014 660 | 0,76% | Akcje |
| GOLDMAN SACHS GROUP INC | $548 715 710 | 1 990 408 | 0,75% | Akcje |
| Legal & General Group Plc | $542 779 462 | 1 968 875 | 0,74% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $499 838 165 | 1 813 110 | 0,68% | Akcje |
| Amundi | $472 966 222 | 1 715 636 | 0,65% | Akcje |
| Bank of New York Mellon Corp | $450 936 717 | 1 635 725 | 0,62% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $409 669 412 | 1 476 499 | 0,56% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $409 373 497 | 1 484 959 | 0,56% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $396 029 634 | 1 436 556 | 0,54% | Akcje |
| NATIONAL BANK OF CANADA /FI/ | $396 005 041 | 1 436 453 | 0,54% | Akcje |
| Nuveen, LLC | $372 070 579 | 1 349 647 | 0,51% | Akcje |
| Capital World Investors | $365 436 721 | 1 325 583 | 0,50% | Akcje |
| DEUTSCHE BANK AG\ | $352 569 909 | 1 278 910 | 0,48% | Akcje |
| Capital Research Global Investors | $340 312 625 | 1 234 448 | 0,46% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $297 765 000 | 1 080 111 | 0,41% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295 639 232 | 1 072 400 | 0,40% | Opcja kupna |
| RAYMOND JAMES FINANCIAL INC | $285 021 252 | 1 033 884 | 0,39% | Akcje |
| BloombergSen Inc. | $250 400 144 | 908 300 | 0,34% | Opcja kupna |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241 311 801 | 875 333 | 0,33% | Akcje |
| Russell Investments Group, Ltd. | $233 022 643 | 844 481 | 0,32% | Akcje |
| BRANDES INVESTMENT PARTNERS, LP | $232 489 133 | 843 317 | 0,32% | Akcje |
| National Pension Service | $218 948 088 | 794 211 | 0,30% | Akcje |
| UBS Group AG | $213 774 402 | 775 444 | 0,29% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $210 159 410 | 762 331 | 0,29% | Akcje |
| Swiss National Bank | $205 012 464 | 743 661 | 0,28% | Akcje |
Insiderzy spółki 41 insiderów · 8 dyrektorzy generalni · 11 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Everett Neville | EVP, Special Advisor to the CEO | 3 września 2026 S | 5 053 | 0 | 2 | $-671 895 |
| Brian C Evanko | President and Chief Executive Officer | 1 września 2026 A | 41 030 | 0 | 0 | $0 |
| David Cordani | Chairman & CEO | 13 maja 2026 M | 57 766 | 1 | 13 | $-58 114 037 |
| Ann M Dennison | EVP, CFO | 27 lutego 2026 A | 7 745 | 0 | 0 | $0 |
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | 18 sierpnia 2026 S | 25 880 | 0 | 3 | $-6 784 615 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | 6 sierpnia 2026 A | · | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | 12 czerwca 2026 M | 2 368 | 0 | 1 | $-268 450 |
| Durga Prasad Koka | EVP, Global CIO | 1 czerwca 2026 F | 6 552 | 0 | 0 | $0 |
| George Kurian | Dyrektor | 31 sierpnia 2026 A | 4 560 | 0 | 0 | $0 |
| Neesha Hathi | Dyrektor | 22 kwietnia 2026 A | 4 151 | 0 | 0 | $0 |
| Philip Ozuah | Dyrektor | 22 kwietnia 2026 A | 2 583 | 0 | 0 | $0 |
| Mark B. Mcclellan | Dyrektor | 22 kwietnia 2026 A | 6 891 | 0 | 0 | $0 |
| Kimberly A. Ross | Dyrektor | 22 kwietnia 2026 A | 5 294 | 0 | 0 | $0 |
| Michael J Hennigan | Dyrektor | 22 kwietnia 2026 A | 1 350 | 0 | 0 | $0 |
| Kathleen M Mazzarella | Dyrektor | 22 kwietnia 2026 A | 6 891 | 0 | 0 | $0 |
| Donna F Zarcone | Dyrektor | 22 kwietnia 2026 A | 27 517 | 0 | 0 | $0 |
| Eric C Wiseman | Dyrektor | 22 kwietnia 2026 A | 23 940 | 0 | 0 | $0 |
| Eric J Foss | Dyrektor | 22 kwietnia 2026 A | 36 696 | 0 | 0 | $0 |
| David J Brailer | · | 29 sierpnia 2025 F | 17 525 | 0 | 0 | $0 |
| Elder Granger | · | 23 kwietnia 2025 A | 6 109 | 0 | 0 | $0 |
| Noelle K Eder | · | 7 marca 2025 S | 13 406 | 0 | 0 | $0 |
| Eric P Palmer | · | 28 lutego 2025 A | 66 160 | 0 | 0 | $0 |
| William J Delaney III | · | 19 sierpnia 2024 M | 17 539 | 0 | 0 | $0 |
| Michael W Triplett | · | 12 sierpnia 2024 M | 32 833 | 0 | 0 | $0 |
| Mary T Hoeltzel | · | 14 maja 2024 M | 2 595 | 0 | 0 | $0 |
| Cynthia Ryan | · | 30 sierpnia 2023 M | 5 937 | 0 | 0 | $0 |
| Paul A Sanford | · | 19 lipca 2023 S | 8 679 | 0 | 0 | $0 |
| Jason D Sadler | · | 24 lutego 2023 A | 47 015 | 0 | 0 | $0 |
| Charles Berg | · | 8 lutego 2023 G | · | 0 | 0 | $0 |
| John Partridge | · | 26 kwietnia 2022 A | 28 177 | 0 | 0 | $0 |
| MURABITO JOHN M | · | 1 marca 2022 F | 51 226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | · | 30 listopada 2021 A | 20 015 | 0 | 0 | $0 |
| Matthew G Manders | · | 19 listopada 2021 F | 43 488 | 0 | 0 | $0 |
| Timothy C Wentworth | · | 12 maja 2021 G | 29 783 | 0 | 0 | $0 |
| Kristen Lauria | · | 30 kwietnia 2021 F | 2 785 | 0 | 0 | $0 |
| Steven B Miller | · | 26 lutego 2021 F | 28 439 | 0 | 0 | $0 |
| William L Roper | · | 26 lutego 2021 A | 8 583 | 0 | 0 | $0 |
| Roman Martinez IV | · | 30 listopada 2020 A | 48 839 | 0 | 0 | $0 |
| Mark L Boxer | · | 28 lutego 2020 F | 49 191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | · | 13 września 2019 S | 13 500 | 0 | 0 | $0 |
| Lisa R Bacus | · | 1 marca 2019 F | 24 024 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 166 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 4,00% | 186 760 SH | 11 września 2026 | Dziennie |
| DUSA · Davis Fundamental ETF Trust | 3,12% | 142 104 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,29% | 86 083 NS | 31 lipca 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,81% | 100 999 SH | 23 października 2026 | Dziennie |
| SMRI · EA Series Trust | 1,79% | 41 365 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,73% | 52 909 SH | 23 października 2026 | Dziennie |
| PWV · Invesco Exchange-Traded Fund Trust | 1,64% | 97 598 SH | 23 października 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,57% | 515 200 SH | 23 października 2026 | Dziennie |
| RUNN · Strategic Trust | 1,57% | 23 601 NS | 31 sierpnia 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1,45% | 2 607 NS | 31 lipca 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 1,36% | 29 890 NS | 31 lipca 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,32% | 88 420 SH | 23 października 2026 | Dziennie |
| IYH · iShares Trust | 1,18% | 152 840 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 1,07% | 792 582 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 1,06% | 125 422 NS | 31 lipca 2026 | N-PORT |
| IMCV · iShares Trust | 1,00% | 41 404 SH | 11 września 2026 | Dziennie |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 573 NS | 31 lipca 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,95% | 11 306 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 0,94% | 139 115 SH | 11 września 2026 | Dziennie |
| RILA · Spinnaker ETF Series | 0,93% | 1 412 NS | 31 lipca 2026 | N-PORT |
| VLUE · iShares Trust | 0,90% | 308 315 SH | 11 września 2026 | Dziennie |
| FBCV · FIDELITY COVINGTON TRUST | 0,88% | 5 567 NS | 31 lipca 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,87% | 43 607 NS | 31 lipca 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,85% | 30 597 177 | 23 października 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,85% | 5 205 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,80% | 24 655 SH | 19 sierpnia 2026 | Dziennie |
| CVY · Invesco Exchange-Traded Fund Trust | 0,78% | 2 959 SH | 23 października 2026 | Dziennie |
| EQIN · Columbia ETF Trust I | 0,77% | 8 375 NS | 31 lipca 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,72% | 56 688 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,69% | 22 309 SH | 23 października 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,63% | 152 491 NS | 31 lipca 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,62% | 1 745 NS | 31 sierpnia 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,61% | 128 339 NS | 31 lipca 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,61% | 18 168 000 | 23 października 2026 | Dziennie |
| CLSE · Trust for Professional Managers | 0,57% | 18 680 NS | 31 sierpnia 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,56% | 24 069 NS | 31 lipca 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,56% | 136 000 | 23 października 2026 | Dziennie |
| FDLO · FIDELITY COVINGTON TRUST | 0,55% | 28 136 NS | 31 lipca 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,55% | 2 200 NS | 31 lipca 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,53% | 1 744 NS | 31 lipca 2026 | N-PORT |
| IMCB · iShares Trust | 0,50% | 29 774 SH | 11 września 2026 | Dziennie |
| QLC · FlexShares Trust | 0,48% | 17 472 NS | 31 lipca 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,48% | 664 NS | 31 lipca 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,46% | 25 557 NS | 31 lipca 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,44% | 2 633 NS | 31 lipca 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,43% | 560 000 | 23 października 2026 | Dziennie |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,43% | 19 438 000 | 23 października 2026 | Dziennie |
| XOEF · iShares Trust | 0,42% | 331 SH | 11 września 2026 | Dziennie |
| DEUS · DBX ETF Trust | 0,39% | 4 285 NS | 31 sierpnia 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,37% | 206 037 NS | 31 lipca 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 1 294 NS | 31 lipca 2026 | N-PORT |
| ESMV · iShares Trust | 0,37% | 102 SH | 11 września 2026 | Dziennie |
| CATH · Global X Funds | 0,35% | 16 346 NS | 31 lipca 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,35% | 112 339 SH | 23 października 2026 | Dziennie |
| MGV · VANGUARD WORLD FUND | 0,34% | 166 268 SH | 19 sierpnia 2026 | Dziennie |
| DGRO · iShares Trust | 0,33% | 509 486 SH | 11 września 2026 | Dziennie |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 9 701 NS | 31 lipca 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 52 531 NS | 31 lipca 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,30% | 1 042 139 SH | 19 sierpnia 2026 | Dziennie |
| EVUS · iShares Trust | 0,30% | 4 037 SH | 11 września 2026 | Dziennie |
| DFVX · Dimensional ETF Trust | 0,28% | 5 359 NS | 31 lipca 2026 | N-PORT |
| IWX · iShares Trust | 0,27% | 37 789 SH | 11 września 2026 | Dziennie |
| VTV · VANGUARD INDEX FUNDS | 0,27% | 2 516 218 SH | 19 sierpnia 2026 | Dziennie |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 4 203 NS | 31 lipca 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,25% | 60 916 SH | 19 sierpnia 2026 | Dziennie |
| IVE · iShares Trust | 0,25% | 438 897 SH | 11 września 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,25% | 20 149 NS | 31 lipca 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,24% | 1 532 NS | 31 lipca 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,24% | 6 130 SH | 19 sierpnia 2026 | Dziennie |
| IUSV · iShares Trust | 0,24% | 231 763 SH | 11 września 2026 | Dziennie |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,23% | 6 395 NS | 31 sierpnia 2026 | N-PORT |
| CHRI · Global X Funds | 0,22% | 64 NS | 31 lipca 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,22% | 6 802 000 | 22 października 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 705 891 SH | 23 października 2026 | Dziennie |
| IQSU · New York Life Investments ETF Trust | 0,22% | 2 603 NS | 31 lipca 2026 | N-PORT |
| SUSL · iShares Trust | 0,22% | 9 336 SH | 11 września 2026 | Dziennie |
| ACVF · ETF Opportunities Trust | 0,21% | 1 165 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,21% | 40 359 SH | 11 września 2026 | Dziennie |
| ILCV · iShares Trust | 0,21% | 9 900 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,21% | 4 094 NS | 31 lipca 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 14 065 SH | 11 września 2026 | Dziennie |
| USSG · DBX ETF Trust | 0,21% | 4 390 NS | 31 sierpnia 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,20% | 157 624 SH | 19 sierpnia 2026 | Dziennie |
| IWD · iShares Trust | 0,20% | 580 231 SH | 11 września 2026 | Dziennie |
| ACWV · iShares, Inc. | 0,19% | 23 190 SH | 11 września 2026 | Dziennie |
| ESGU · iShares Trust | 0,19% | 122 944 SH | 11 września 2026 | Dziennie |
| ROUS · Lattice Strategies Trust | 0,19% | 4 742 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,19% | 27 932 SH | 23 października 2026 | Dziennie |
| MPLY · Strategy Shares | 0,18% | 104 NS | 31 lipca 2026 | N-PORT |
| SNPE · DBX ETF Trust | 0,18% | 19 030 NS | 31 sierpnia 2026 | N-PORT |
| SIZE · iShares Trust | 0,18% | 2 691 SH | 11 września 2026 | Dziennie |
| GLBL · Pacer Funds Trust | 0,18% | 7 NS | 31 lipca 2026 | N-PORT |
| USMV · iShares Trust | 0,17% | 144 573 SH | 11 września 2026 | Dziennie |
| EGLE · Global X Funds | 0,17% | 13 NS | 31 lipca 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,15% | 8 296 SH | 23 października 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,15% | 249 847 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,14% | 63 351 NS | 31 lipca 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,14% | 52 742 SH | 19 sierpnia 2026 | Dziennie |
| TOPC · iShares Trust | 0,14% | 159 SH | 11 września 2026 | Dziennie |
| DIVB · iShares Trust | 0,13% | 9 546 SH | 11 września 2026 | Dziennie |
| IWL · iShares Trust | 0,13% | 10 119 SH | 11 września 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,13% | 1 585 SH | 23 października 2026 | Dziennie |
| XVV · iShares Trust | 0,13% | 3 041 SH | 11 września 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,13% | 42 192 SH | 23 października 2026 | Dziennie |
| SPXD · DBX ETF Trust | 0,12% | 32 NS | 31 sierpnia 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,12% | 308 954 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,12% | 59 034 SH | 19 sierpnia 2026 | Dziennie |
| XYLD · Global X Funds | 0,12% | 13 766 NS | 31 lipca 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,12% | 9 915 NS | 31 lipca 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,11% | 1 207 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,11% | 13 352 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,11% | 13 613 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,11% | 203 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,11% | 3 332 808 SH | 11 września 2026 | Dziennie |
| BKLC · BNY Mellon ETF Trust | 0,11% | 21 844 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,11% | 255 NS | 31 lipca 2026 | N-PORT |
| XTR · Global X Funds | 0,11% | 19 NS | 31 lipca 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 35 099 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,11% | 6 870 735 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,11% | 1 059 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,11% | 14 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,11% | 4 302 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,11% | 80 995 NS | 31 lipca 2026 | N-PORT |
| ILCB · iShares Trust | 0,11% | 4 927 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,11% | 209 SH | 23 października 2026 | Dziennie |
| IYY · iShares Trust | 0,11% | 11 380 SH | 11 września 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,11% | 998 NS | 31 lipca 2026 | N-PORT |
| IWB · iShares Trust | 0,10% | 180 235 SH | 11 września 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,10% | 6 372 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 2 681 SH | 23 października 2026 | Dziennie |
| ESG · FlexShares Trust | 0,10% | 480 NS | 31 lipca 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,10% | 21 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,10% | 343 920 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,10% | 71 744 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,10% | 8 400 121 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,10% | 43 269 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,10% | 21 990 SH | 19 sierpnia 2026 | Dziennie |
| LGDX · Tidal Trust III | 0,10% | 497 NS | 31 lipca 2026 | N-PORT |
| APUE · Trust for Professional Managers | 0,09% | 8 521 NS | 31 sierpnia 2026 | N-PORT |
| TILT · FlexShares Trust | 0,09% | 7 268 NS | 31 lipca 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,09% | 1 842 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,09% | 744 SH | 11 września 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,09% | 20 684 NS | 31 lipca 2026 | N-PORT |
| KOKU · DBX ETF Trust | 0,08% | 2 436 NS | 31 sierpnia 2026 | N-PORT |
| URTH · iShares, Inc. | 0,08% | 23 813 SH | 11 września 2026 | Dziennie |
| LRGF · iShares Trust | 0,08% | 10 058 SH | 11 września 2026 | Dziennie |
| ACWI · iShares Trust | 0,07% | 83 068 SH | 11 września 2026 | Dziennie |
| USCL · iShares Trust | 0,07% | 6 976 SH | 11 września 2026 | Dziennie |
| NULC · Nushares ETF Trust | 0,06% | 152 NS | 31 lipca 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,06% | 219 986 SH | 19 sierpnia 2026 | Dziennie |
| GLOF · iShares Trust | 0,02% | 150 SH | 11 września 2026 | Dziennie |
| PEVC · Pacer Funds Trust | 0,01% | 1 NS | 31 lipca 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 101 800 | 22 października 2026 | Dziennie |
| NPFE · Elevation Series Trust | 0,00% | 21 NS | 31 lipca 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0,00% | 400 | 12 października 2026 | Dziennie |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| VCEB · VANGUARD WORLD FUND | · | · | 30 lipca 2026 | Dziennie |
CI Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
24 analityków · 2026-10-24Średnia cel $342.29 +11,9%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.